NSE: APOLLOHOSP | BSE: 508869

Mid-range Performer

Download real time

7275.50 -75.00 (-1.02%)

Near 52W High of ₹7635.00

55,680 NSE+BSE Volume

NSE 18 Jul, 2025 10:44 AM (IST)

104,610.6

Market Cap

Market Runner Up

0.7

Beta 1Year

Very Low volatility

Dividend

Apollo Hospitals Enterprise Ltd. has an upcoming dividend of ₹10.00 per share due on 19 Aug 2025 See details

Apollo Hospitals Enterprise Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for APOLLOHOSP, BSE:508869 Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise Ltd.

19 Nov 2020

7275.50

-1.02%

SAMVAT 2077

Buy: Apollo Hospitals Enterpris...

Recommendation Target

Karvy

On the technical front, APOLLOHOSP has been making higher highs and higher lows on the daily charts and is currently placed above the medium-term EMAs in the daily frame. In the recent past, after clocking a low of 1986 levels, the stock has witnessed a bounce and rallied to the current levels. At the current juncture, the stock has formed a base of around 1985 levels on the lower side and is all set to move higher.

Apollo Hospitals Enterprise Ltd. is trading above all available SMAs

Apollo Hospitals Enterprise Ltd.

13 Nov 2020

7275.50

-1.02%

Apollo Hospitals

Hold: Apollo Hospitals Enterpris...

Recommendation Target

ICICI Securities Limited

Healthcare expansion moderates; focus on asset sweating Rapid expansion and maturity of older hospitals has kept overall growth tempo at 12-14% per annum. After a prolonged capex cycle, especially in FY14-18, Apollo is focusing on profitability and return ratios with capex moderation. This has reflected in a marked improvement in both EBITDA margins and RoCE. The new hospitals, ventures are turning profitable ahead of schedule on the back of a judicious case mix besides better occupancy and other matrix. We expect healthcare sales to grow at 9.5% FY20-23E...

Promoters released all pledges in Jun 2025 qtr.

Apollo Hospitals Enterprise Ltd.

16 Sep 2020

7275.50

-1.02%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Target

ICICI Securities Limited

Healthcare expansion moderates; focus on asset sweating Notwithstanding short-term fluctuations stemming from Covid, rapid expansion, maturity of older hospitals have kept overall growth tempo at 1214% per annum. After an intense capex cycle, especially in FY14-18, the company is focusing on profitability, return ratios with calculated capex moderation. This reflected in a marked improvement in both EBITDA margins, RoCE. The new hospitals and ventures are turning profitable ahead of schedule on the back of a judicious case mix besides better occupancy and other matrix. We expect healthcare sales to grow at ~8% CAGR in FY2022E to | 7544 crore mainly due to growth at new hospitals, AHLL....

Number of FII/FPI investors increased from 1548 to 1626 in Jun 2025 qtr.

Apollo Hospitals Enterprise Ltd.

28 Jun 2020

7275.50

-1.02%

Apollo Hospital

Sell: Apollo Hospitals Enterpris...

Yes Securities

Ascribe 9x EV/EBIDTA to FY22 EBIDTA and 1x EV/sales eachtopharmacyandAHLLbusinesses;significantlybelow consensusonvaluationgiventhesubparoperatingmetrics...

Number of FII/FPI investors increased from 1548 to 1626 in Jun 2025 qtr.

Apollo Hospitals Enterprise Ltd.

03 Apr 2020

7275.50

-1.02%

Hospital Sector Report

Buy: Apollo Hospitals Enterpris...

Target

ICICI Securities Limited

The impact of Covid-19 outbreak has taken a toll on hospital stocks most of which have corrected anywhere between 20% and 50% in the last month. We spoke with a few of them to assess the impact and way forward. Large players like Apollo Hospitals have seen a significant drop in occupancy levels to 40% from 69% amid restrictions on people movement (~50% patient volume are travelling patients) and postponement of elective procedures. Fortis has also started seeing a decline in number of elective surgeries resulting in a sharp fall of ~65%, 40% in OPD, IPD volumes,...

Number of MF schemes increased from 305 to 324 in Jun 2025 qtr.

Apollo Hospitals Enterprise Ltd.

14 Feb 2020

7275.50

-1.02%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Target

ICICI Securities Limited

Healthcare expansion moderates; focus on asset sweating Rapid expansion and maturity of older hospitals has kept the overall growth tempo at 12-14% per annum. After an intense capex cycle, especially during FY14-18, the company is focusing on the profitability and return ratios with calculated capex moderation. This has reflected in a marked improvement in both EBITDA margins and RoCE. The new hospitals and ventures are turning profitable ahead of schedule on the back of a judicious case mix besides better occupancy and other matrix. We expect healthcare sales to...

Prabhudas Lilladhar increased Buy price target of Apollo Hospitals Enterprise Ltd. to 8350.0 on 02 Jul, 2025.

Apollo Hospitals Enterprise Ltd.

10 Dec 2019

7275.50

-1.02%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

ICICI Securities Limited

The pharmacy business (40% of FY19 revenues) has grown at ~22% CAGR in the last five years on the back of consistent addition of new pharmacies and timely closure of non-performing pharmacies. FY19 margins were at 5.2%. We expect the pharmacy business to grow at ~15% CAGR in FY1922E to | 5129 crore mainly on the back of new addition and improvement in...

Promoters released all pledges in Jun 2025 qtr.

Apollo Hospitals Enterprise Ltd.

10 Dec 2019

7275.50

-1.02%

Hospital Sector Report

Buy: Apollo Hospitals Enterpris...

ICICI Securities Limited

In the last three to four years, with many frontline large cap pharma companies being hampered by structural US related & other issues, we have seen growing investors' preference for healthcare services providers. At the same time, as many as four hospitals and three diagnostic companies got listed on the bourses, thus providing a much larger basket for investors. Some peculiar factors responsible for growing interest in the hospitals space are: 1) waning high capex episodes of private hospitals after the 2008-18 capex cycle, 2) shifting focus towards assets light model for most hospital...

Apollo Hospitals Ent.. has an average target of 7660.40 from 5 brokers.

Apollo Hospitals Enterprise Ltd.

18 Nov 2019, 12:00AM

7275.50

-1.02%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Recommendation Target

ICICI Securities Limited

Healthcare expansion moderates; focus on asset sweating Rapid expansion and maturity of older hospitals has kept the overall growth tempo at 12-14% per annum. However, constant addition is likely to put some pressure on EBITDA margins and return ratios in the short to medium term. Similarly, existing hospital margins are being compressed due to 1) regulation on stent/implants pricing, 2) negative GST impact and 3) higher guarantee fees to the doctors. However, in the past, the company has demonstrated its ability to balance between expansion and profitability. We...

Apollo Hospitals Ent.. has an average target of 7660.40 from 5 brokers.

Apollo Hospitals Enterprise Ltd.

29 Aug 2019

7275.50

-1.02%

APOLLO HOSPITAL

Hold: Apollo Hospitals Enterpris...

Recommendation Target

Geojit BNP Paribas

Margins up strongly leading to PAT growth Net sales grew 16.8% YoY to Rs. 2,234cr in Q1FY20. EBITDA, adjusted for Ind AS 116 adoption, grew ~21.0% YoY to Rs. 274cr in Q1FY20. Adjusted EBITDA margin came in at 12.3% (up 43bps YoY) due to strong performance from mature hospitals, whose adjusted EBITDA margin stood at 22.1%. Adjusted EBITDA rose 21.0% YoY to Rs....

Apollo Hospitals Ent.. has an average target of 7660.40 from 5 brokers.

Is Apollo Hospitals Enterprise Ltd. worth buying?

226 Votes:

Buy 70.8%

Sell 20.35%

Hold 8.85%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf